MDS Virtual Congress 2021 Archives - Page 132 of 132

Whole genome sequencing aids in diagnosing GCH1 dopa responsive dystonia in two Peruvian patients and influences medical management

L. Urbina-Ramirez, J. La Serna-Infantes, E. Sarapura-Castro, A. Rivera-Valdivia, E. Thorpe, D. Perry, K. Milla-Neyra, C. Galarreta, M. Dueñas-Roque, M. Cornejo-Olivas (Lima, Peru)
Whole-Exome Sequencing in a Movement Disorders Clinic

C. Shah, L. Robak, E. Hill, J. Jankovic (Houston, USA)
Whole-transcriptome analysis of monocyte-derived macrophages from patients with Parkinson’s disease associated with mutations in the GBA gene

T. Usenko, A. Panteleeva, K. Basharova, M. Nikolaev, A. Kopytova, A. Bezrukova, K. Senkevich, I. Miliukhina, E. Zakharova, S. Pchelina (Gatchina, Russian Federation)
Widespread loss of presynaptic terminal marker SV2A in early Huntington’s disease.

A. Delva, L. Michiels, M. Koole, K. van Laere, W. Vandenberghe (Leuven, Belgium)
Yoga for Functional Neurological Disorder – Two Case Descriptions

D. Kipnis, H. Shah, L. Quinn (New York, USA)
α-synuclein and deficits of membrane trafficking in Parkinson’s Disease

A. Sarchione, A. Marchand, F. Filippini, T. Galli, JM. Taymans, MC. Chartier-Harlin (Lille, France)
α-synuclein expression is not mediated by β2-adrenoreceptor modulation in human dopaminergic cells

M. Langmyhr, IH. Flønes, CC. Cappelletti, C. Tzoulis, M. Toft (Oslo, Norway)
α-Synuclein in sympathetic nerve fibers distinguishes PRKN from LRRK2 and other genetic forms of Parkinson’s Disease

R. Isonaka, D. Goldstein, W. Zhu, E. Yoon, D. Ehrlich, A. Schindler, A. Kokkinis, M. Sabir, S. Scholz, S. Bandres-Ciga, C. Blauwendraat, P. Gonzalez-Alegre, G. Lopez, E. Sidransky, D. Narendra (Bethesda, USA)